Miscellaneous Pulmonary Trials

Researchers in the Duke Division of Pulmonary, Allergy, and Critical Care Medicine are pursuing a number of miscellaneous clinical trials in order to understand the mechanisms of a variety of lung diseases.

Current Clinical Trials

The following clinical research initiatives are being conducted in our division:

⨀ Hypereosinophilic Syndrome:

A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (NATRON) (PI: Bressler)

This is a randomized, double-blind, 24-week Phase III study to compare the efficacy and safety of benralizumab vs. placebo administered by SC injections every 4 weeks in patients with hypereosinophilic syndorome (HES). Patients will be randomized to receive either benralizumab or placebo during the 24-week study period. The target population is adult patients with symptomatic active HES.

Principal Investigator: Peter Bressler, MD
Status: On-Hold
IRB Number: Pro00103948
Clinical Trials.gov #: NCT04191304
Study Team Contact: Jessica Shier – jessica.shier@duke.edu


Enroll in a Pulmonary Clinical Trial at Duke

Researchers in our division are investigating a variety of treatments and therapies to respond to lung disease.
Click here  to view a list of current clinical trials for Pulmonary.